This site is intended for healthcare professionals
News

EU approves Piqray for HR+/HER2- locally advanced or metastatic breast cancer.- Novartis

Read time: 1 mins
Last updated:30th Jul 2020
Published:30th Jul 2020
Condition: Breast Cancer HER2-
Type: drug
Register free for full access to medthority.com